First Bard Vein Filter Bellwether Heads to Jury
By Cara Salvatore Law360
Law360, Phoenix (March 29, 2018, 11:30 PM EDT) – a Phoenix federal jury began deliberations Thursdays in the first bellwether trial in multidistrict litigation over claims that device maker Bard’s clot-stopping vein implants splinted and migrated towards patients’ hearts, after Bard closed its case by arguing evidence concerning predecessor implants and FDA warnings were red herrings . . .
Latest Posts
by Gay MennutiBeus Gilbert McGroder welcomes its newest members: Timothy J. Casey and Michael K. Kelly
Mr. Casey is widely regarded as one of Arizona’s preeminent trial attorneys. His experience in high-stakes litigation includes plaintiff’s...
by Gay MennutiBeus Gilbert McGroder congratulates its following new members:
Megan Beus | Paul Dirkmaat | Patrick J. McGroder IV | Alex Morris | Reed Willis
by Gay MennutiBeus Gilbert McGroder Named In “Best Law Firms” (2021 Edition)
The law firm of Beus Gilbert McGroder PLLC received national and metropolitan Phoenix rankings in the U.S. News – Best Lawyers® 2021 list of “Best Law...